Forte Biosciences, Inc. (FBRX) Financials

FBRX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 47.9 million 7.5 million
2023-06-30 31.2 million 6.3 million
2023-03-31 36.7 million 3.8 million
2022-12-31 42.0 million 3.2 million

FBRX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -9.1 million 772000
2023-06-30 -5.5 million 855000
2023-03-31 -5.2 million 877000
2022-12-31 -2.9 million 860000

FBRX Net Income

No data available :(

FBRX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 46.2 million - -
2023-06-30 30.4 million - -
2023-03-31 35.9 million - -
2022-12-31 41.1 million - -

FBRX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 37.9 million
2023-06-30 21.0 million
2023-03-31 21.0 million
2022-12-31 17.4 million

FBRX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 71000 6.4 million 3.8 million -
2023-06-30 - 7.1 million 1.9 million -
2023-03-31 - 4.8 million 2.1 million -
2022-12-31 - 2.5 million 2.5 million -

FBRX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 3000
2023-06-30 - -
2023-03-31 - -
2022-12-31 - -

FBRX

Price: $0.68

52 week price:
0.38
1.15

Earnings Per Share: -1.00 USD

P/E Ratio: -0.52

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 50864

Market Capitalization: 26.2 million

Links: